Learn More
Medchemexpress LLC Xl888 | 1149705-71-4 | MFCD22124888 | 99.4% | C29H37N5O3 | 10MG

Supplier: Medchemexpress LLC HY1331310MG
XL888 is an orally bioavailable, ATP-competitive small-molecule inhibitor of heat shock protein 90 (HSP90) used in oncology research. It destabilizes HSP90 client proteins, leading to cell cycle arrest and apoptosis, and has demonstrated anti-proliferative and anti-tumor activity in preclinical studies. Reported biochemical potency against HSP90 is ~24 nM.
- Orally bioavailable small-molecule suitable for in vivo and in vitro studies.
- ATP-competitive mechanism that targets HSP90 chaperone activity.
- Demonstrated anti-proliferative and pro-apoptotic effects in cancer cell lines.
- Reported low nanomolar biochemical potency in cell-free assays.
- Useful for pharmacology and mechanism-of-action studies involving HSP90 clients.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.